Carbonyl reductase 2 Antibodies

Santa Cruz Biotechnology provides a broad selection of Carbonyl Reductase 2 monoclonal antibodies for research applications. Carbonyl reductase 2 Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carbonyl reductase 2 is a key enzyme involved in the reduction of carbonyl compounds, playing a significant role in drug metabolism and the detoxification of harmful substances. Its function is crucial in maintaining cellular homeostasis and influencing various metabolic pathways. Understanding the activity and regulation of Carbonyl Reductase 2 is essential for elucidating its implications in diseases such as cancer and metabolic disorders. Researchers can utilize specific monoclonal antibodies to investigate protein expression patterns across different tissues and cell types. Advanced research techniques incorporating Carbonyl Reductase 2 monoclonal antibodies enable detailed analysis of enzyme localization and interactions. Comprehensive studies of Carbonyl Reductase 2 expression and activity patterns contribute valuable insights into cellular metabolism and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for Carbonyl Reductase 2 support the scientific community in advancing our understanding of metabolic processes and potential therapeutic targets.